Peeples-Dyer Veleka 4
4 · Replimune Group, Inc. · Filed Apr 7, 2026
Research Summary
AI-generated summary of this filing
Replimune Group (REPL) Director Veleka Peeples-Dyer Receives Award
What Happened
Veleka Peeples-Dyer, a director of Replimune Group, was granted 44,500 derivative shares/options on April 1, 2026. The award was recorded at $0.00 per share (no cash paid), so the reported acquisition value is $0. The filing notes the underlying shares vest in full on April 1, 2027. The Form 4 was filed late due to an inadvertent administrative error.
Key Details
- Transaction date: 2026-04-01. Transaction code: A (award/grant of a derivative security).
- Amount: 44,500 shares; Price/Consideration: $0.00 per share; reported dollar value: $0.
- Vesting: Footnote indicates all shares underlying this option vest on 2027-04-01.
- Shares owned after transaction: Not disclosed in this Form 4.
- Filing timeliness: Late filing noted in the remarks (inadvertent administrative error). This reduces short-term transparency until corrected.
Context
This was a grant/award of a derivative security (not a cash purchase or a sale). Because the award vests later, there is no immediate change in tradable shares unless/until vested and exercised. Grants to directors are typically compensation-related; they do not by themselves indicate a buy or sell decision by the insider. The late filing corrects the public record but does not, by itself, provide insight into the insider’s trading intent.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-04-01+44,500→ 44,500 totalExercise: $7.61Exp: 2036-04-01→ Common Stock (44,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest entirely on April 1, 2027.